Zydus Lifesciences Ltd

Zydus Lifesciences Ltd | Sector: Pharmaceuticals | ISIN: INE010B01027

₹ 435.45 (0.90%) icon

1 Feb, 2023, 3:43:39 PM
Open
₹ 434.10
Prev. Close
₹ 431.55
Turnover(lac)
₹ 5,216.27
Day's High
₹ 444.50
Day's Low
₹ 430.85
52 Wk High
₹ 459.00
52 Wk Low
₹ 319.00
Book Value
₹ 138.53
Face Value
₹ 1.00
Mkt. Cap (Cr.)
₹ 44,076.43
P/E
35.94
EPS
12.12
Div. Yield
0.58

Stock View

info icon
Edit Image

HOLD

Target | 12 Jan, 2023

457.549 (6.02%)

Zydus Lifesciences Ltd., formerly Cadila Healthcare Limited, is an India-based life sciences company. The Company is focused on delivering care and nurturance for the patients, backed by sci... Read More

KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 01-02-2023 15:43:39

    ₹ 435.45 3.90 0.90
  • Open
  • ₹ 434.1
  • Prev. Close
  • ₹ 431.55
  • Turnover(Lac.)
  • ₹ 5,216
  • Day's High
  • ₹ 444.5
  • Day's Low
  • ₹ 430.85
  • 52 Week's High
  • ₹ 459
  • 52 Week's Low
  • ₹ 319
  • Book Value
  • ₹ 138.53
  • Face Value
  • ₹ 1
  • Mkt Cap (₹ Cr.)
  • 44,076.43
  • P/E
  • 35.94
  • EPS
  • 12.12
  • Divi. Yield
  • 0.58

Corporate Actions

05 Dec , 2022

12:00 AM

29 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Oct , 2022

12:00 AM

03 Aug , 2022

12:00 AM

20 May , 2022

12:00 AM

AGM

Announcement date: 20 May , 2022

View Details

03 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 May , 2022

12:00 AM

Dividend

Dividend amount: 2.5
Announcement date: 20 May , 2022

View Details

13 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Jan , 2022

12:00 AM

25 Jan , 2022

12:00 AM

25 Jan , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

SHAREHOLDING SNAPSHOT
02 February , 2023 | 04:56 AM

PROMOTER - TOTAL74.98%

Indian: 74.98%

Foreign: 0%

NON-PROMOTER - TOTAL 25.02%

Institutions: 16.21%

Non-Institutions: 8.81%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more

Zydus Lifesciences Ltd News and Update

Image not found
  • 14 hours ago |
  • 2:50 PM

Today's Budget has every potential to bring out a broad-based revival in the Indian economy.

Image not found
Article Image
  • IIFL News Service |
  • 30 January, 2023 |
  • 2:47 PM
ad IconAd Image

FINANCIALS

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Zydus Lifesciences Ltd

  • Pankaj R Patel

  • Chairman (Non-Executive)
  • Sharvil P Patel

  • Managing Director
  • Mukesh M Patel

  • Director
  • Nitin Raojibhai Desai

  • Independent Director
  • Dharmishta N Rawal

  • Independent Director
  • Apurva S Diwanji

  • Independent Director
  • Ganesh N Nayak

  • Executive Director
  • Bhadresh K Shah

  • Independent Director
  • Dhaval N Soni

  • Company Secretary

Summary

Zydus Lifesciences Ltd. (Formerly known as Cadila Healthcare Ltd.) is one of the leading innovation driven pharmaceutical companiesin India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing,marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, includingbiosimilars and vaccines), active pharmaceutical ingredients (APIs), animal healthcare products and consumer wellness products. The Company has their manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh.Founded by the Late Promoter, Mr. Ramanbhai B. Patel, the Company was incorporated in May, 1995 and converted into a Public Limited Company in July, 1996. The Companys operation includes pharmaceuticals, which includes human formulations, veterinary formulations and bulk durgs, diagnostics, herbal products, skin care products and OTC products. In the year 1996, the Company made a strategic alliance with Gulin Pharma of China and launched Falcigo in India, which is an anti-malarial segment. In May 2000, the company acquired formulation business of Recon Ltd, which strengthens the company in the southern market. In the year 2001, they acquired German Remedies which was the largest M&A in the Indian Pharmaceutical sector and in the same year, they entered into a joint venture with US based Onconova for collaborative... Read More


Reports by Zydus Lifesciences Ltd


Reports by Zydus Lifesciences Ltd